• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于缺氧-免疫的口腔鳞状细胞癌预后mRNA特征的鉴定与验证

Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma.

作者信息

Lv Shaohua, Qian Zhipeng, Li Jianhao, Piao Songlin, Li Jichen

机构信息

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150081, China.

Stomatology School, Harbin Medical University, 143 Yiman Street, Nangang District, Harbin, Heilongjiang, China.

出版信息

J Oncol. 2022 Feb 7;2022:5286251. doi: 10.1155/2022/5286251. eCollection 2022.

DOI:10.1155/2022/5286251
PMID:35178089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8844353/
Abstract

BACKGROUND

Oral squamous cell carcinoma (OSCC) is a commonly encountered head and neck malignancy. Increasing evidence shows that there are abnormal immune response and chronic cell hypoxia in the development of OSCC. However, there is a lack of a reliable hypoxia-immune-based gene signature that may serve to accurately prognosticate OSCC.

METHODS

The mRNA expression data of OSCC patients were extracted from the TCGA and GEO databases. Hypoxia status was identified using the t-distributed Stochastic Neighbor Embedding (t-SNE) algorithm. Both ESTIMATE and single-sample gene-set enrichment analysis (ssGSEA) were used for further evaluation of immune status. The DEGs in different hypoxia and immune status were determined, and univariate Cox regression was used to identify significantly prognostic genes. A machine learning method, least absolute shrinkage and selection operator (LASSO) Cox regression analysis, allowed us to construct prognostic gene signature to predict the overall survival (OS) of OSCC patients.

RESULTS

A total of 773 DEGs were identified between hypoxia high and low groups. According to immune cell infiltration, patients were divided into immune high, medium, and low groups and immune-associated DEGs were identified. A total of 193 overlapped DEGs in both immune and hypoxia status were identified. With the univariate and LASSO Cox regression model, eight signature mRNAs (FAM122C, RNF157, RANBP17, SOWAHA, KIAA1211, RIPPLY2, INSL3, and DNAH1) were selected for further calculation of their respective risk scores. The risk score showed a significant association with age and perineural and lymphovascular invasion. In the GEO validation cohort, a better OS was observed in patients from the low-risk group in comparison with those in the high-risk group. High-risk patients also demonstrated different immune infiltration characteristics from the low-risk group and the low-risk group showed potentially better immunotherapy efficacy in contrast to high-risk ones.

CONCLUSION

The hypoxia-immune-based gene signature has prognostic potential in OSCC.

摘要

背景

口腔鳞状细胞癌(OSCC)是一种常见的头颈部恶性肿瘤。越来越多的证据表明,在OSCC的发生发展过程中存在异常免疫反应和慢性细胞缺氧。然而,缺乏一种可靠的基于缺氧-免疫的基因特征来准确预测OSCC的预后。

方法

从TCGA和GEO数据库中提取OSCC患者的mRNA表达数据。使用t分布随机邻域嵌入(t-SNE)算法确定缺氧状态。采用ESTIMATE和单样本基因集富集分析(ssGSEA)进一步评估免疫状态。确定不同缺氧和免疫状态下的差异表达基因(DEGs),并使用单变量Cox回归来识别具有显著预后意义的基因。一种机器学习方法,即最小绝对收缩和选择算子(LASSO)Cox回归分析,使我们能够构建预后基因特征来预测OSCC患者的总生存期(OS)。

结果

在缺氧高分组和低分组之间共鉴定出773个DEGs。根据免疫细胞浸润情况,将患者分为免疫高、中、低三组,并鉴定出免疫相关的DEGs。在免疫和缺氧状态下共鉴定出193个重叠的DEGs。通过单变量和LASSO Cox回归模型,选择了8个特征mRNA(FAM122C、RNF157、RANBP17、SOWAHA、KIAA1211、RIPPLY2、INSL3和DNAH1)进一步计算它们各自的风险评分。风险评分与年龄、神经周围和淋巴管侵犯显著相关。在GEO验证队列中,低风险组患者的OS明显优于高风险组患者。高风险患者与低风险组也表现出不同的免疫浸润特征,与高风险患者相比,低风险组显示出潜在更好的免疫治疗效果。

结论

基于缺氧-免疫的基因特征在OSCC中具有预后潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/b95a3789f793/JO2022-5286251.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/577078a01503/JO2022-5286251.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/5d716fc994d8/JO2022-5286251.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/41ceeed94f75/JO2022-5286251.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/24c03339e25f/JO2022-5286251.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/ea0ddf99cee8/JO2022-5286251.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/b95a3789f793/JO2022-5286251.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/577078a01503/JO2022-5286251.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/5d716fc994d8/JO2022-5286251.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/41ceeed94f75/JO2022-5286251.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/24c03339e25f/JO2022-5286251.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/ea0ddf99cee8/JO2022-5286251.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/8844353/b95a3789f793/JO2022-5286251.006.jpg

相似文献

1
Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma.基于缺氧-免疫的口腔鳞状细胞癌预后mRNA特征的鉴定与验证
J Oncol. 2022 Feb 7;2022:5286251. doi: 10.1155/2022/5286251. eCollection 2022.
2
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.基于 ssGSEA 的新型免疫相关基因特征识别口腔鳞状细胞癌患者肿瘤微环境和预测疾病预后:一项生物信息学和生物学验证研究。
Front Immunol. 2022 Jul 6;13:922195. doi: 10.3389/fimmu.2022.922195. eCollection 2022.
3
Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma.一种4-长链非编码RNA糖酵解相关特征在口腔鳞状细胞癌中的预后意义
J Dent Sci. 2022 Apr;17(2):991-1000. doi: 10.1016/j.jds.2021.11.002. Epub 2021 Nov 27.
4
Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.用于预测透明细胞肾细胞癌临床预后和免疫治疗反应的缺氧与代谢相关联合预后特征的开发与验证
Front Oncol. 2023 Nov 10;13:1162846. doi: 10.3389/fonc.2023.1162846. eCollection 2023.
5
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma.一种基于3种mRNA的口腔鳞状细胞癌生存预后特征。
PeerJ. 2019 Jul 31;7:e7360. doi: 10.7717/peerj.7360. eCollection 2019.
6
Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.基于单样本基因集富集分析(ssGSEA)算法的免疫相关基因特征在肝细胞癌预后及免疫格局中的综合分析
Front Genet. 2022 Dec 9;13:1064432. doi: 10.3389/fgene.2022.1064432. eCollection 2022.
7
Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.鉴定并验证八个与癌症相关的成纤维细胞相关基因作为头颈部鳞状细胞癌的预后标志物。
Heliyon. 2023 Feb 28;9(3):e14003. doi: 10.1016/j.heliyon.2023.e14003. eCollection 2023 Mar.
8
Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中FGFR信号相关预后模型及免疫景观的研究
Front Cell Dev Biol. 2022 Feb 14;9:801715. doi: 10.3389/fcell.2021.801715. eCollection 2021.
9
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.结肠癌中缺氧相关亚型的鉴定、预后模型的建立及肿瘤微环境浸润特征
Front Genet. 2022 Jun 17;13:919389. doi: 10.3389/fgene.2022.919389. eCollection 2022.
10
Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.用于预测口腔鳞状细胞癌生存的自噬相关基因特征及列线图的开发与验证
Front Oncol. 2020 Oct 16;10:558596. doi: 10.3389/fonc.2020.558596. eCollection 2020.

引用本文的文献

1
RNF157 targets RIG-I/DDX58 to promote proliferation in liver cancer.RNF157靶向维甲酸诱导基因I/DDX58以促进肝癌增殖。
BMC Cancer. 2025 May 1;25(1):816. doi: 10.1186/s12885-025-14224-7.
2
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma.口腔鳞状细胞癌中MRI影像组学与免疫基因表达特征之间的相互作用
Sci Rep. 2025 Apr 12;15(1):12622. doi: 10.1038/s41598-025-96821-x.
3
A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression.使用LASSO Cox回归对口腔鳞状细胞癌预后基因特征的叙述性综述

本文引用的文献

1
Heterogeneity analysis of the immune microenvironment in laryngeal carcinoma revealed potential prognostic biomarkers.喉癌免疫微环境的异质性分析揭示了潜在的预后生物标志物。
Hum Mol Genet. 2022 May 4;31(9):1487-1499. doi: 10.1093/hmg/ddab332.
2
A novel defined hypoxia-related gene signature to predict the prognosis of oral squamous cell carcinoma.一种用于预测口腔鳞状细胞癌预后的新型缺氧相关基因特征。
Ann Transl Med. 2021 Oct;9(20):1565. doi: 10.21037/atm-21-4990.
3
The impact of hypoxia on immune state in cancer.缺氧对癌症免疫状态的影响。
Biomedicines. 2025 Jan 8;13(1):134. doi: 10.3390/biomedicines13010134.
4
MMP14 expression levels accurately predict the presence of extranodal extensions in oral squamous cell carcinoma: a retrospective cohort study.MMP14 表达水平能准确预测口腔鳞状细胞癌的结外侵犯:一项回顾性队列研究。
BMC Cancer. 2023 Feb 10;23(1):142. doi: 10.1186/s12885-023-10595-x.
5
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.基于 ssGSEA 的新型免疫相关基因特征识别口腔鳞状细胞癌患者肿瘤微环境和预测疾病预后:一项生物信息学和生物学验证研究。
Front Immunol. 2022 Jul 6;13:922195. doi: 10.3389/fimmu.2022.922195. eCollection 2022.
Life Sci. 2021 Dec 1;286:120057. doi: 10.1016/j.lfs.2021.120057. Epub 2021 Oct 16.
4
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer.肝癌中的缺氧、代谢重编程与耐药性
Cells. 2021 Jul 6;10(7):1715. doi: 10.3390/cells10071715.
5
Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.免疫微环境lncRNA修饰因子的泛癌特征揭示了临床上不同的原发性肿瘤亚型。
NPJ Genom Med. 2021 Jun 17;6(1):52. doi: 10.1038/s41525-021-00215-7.
6
Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).生物信息学分析表明,组织蛋白酶G(CTSG)是口腔鳞状细胞癌(OSCC)中一种潜在的免疫相关生物标志物。
Onco Targets Ther. 2021 Feb 25;14:1275-1289. doi: 10.2147/OTT.S293148. eCollection 2021.
7
Tumour-derived Dilp8/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3/8 in the brain.肿瘤衍生的 Dilp8/INSL3 通过大脑中的 Lgr3/8 调节摄食神经肽诱导癌症厌食症。
Nat Cell Biol. 2021 Feb;23(2):172-183. doi: 10.1038/s41556-020-00628-z. Epub 2021 Feb 8.
8
Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.建立并验证了一个基于新型五甲基化 DNA 特征的预后列线图,用于预测子宫内膜癌患者的生存情况。
Cancer Med. 2021 Jan;10(2):693-708. doi: 10.1002/cam4.3576. Epub 2020 Dec 22.
9
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.靶向 CD40 和 PD-L1 通路抑制致癌物诱导的口腔鳞状细胞癌前病变的进展。
Cancer Prev Res (Phila). 2021 Mar;14(3):313-324. doi: 10.1158/1940-6207.CAPR-20-0418. Epub 2020 Dec 4.
10
Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.FoxP3 和 CTLA-4 表达在口腔鳞状细胞癌患者中的预后价值。
PLoS One. 2020 Aug 12;15(8):e0237465. doi: 10.1371/journal.pone.0237465. eCollection 2020.